Patents by Inventor Harald Seulberger

Harald Seulberger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6878536
    Abstract: Genes of purine biosynthesis from Ashbya gossypii are used in microbial riboflavin synthesis.
    Type: Grant
    Filed: February 15, 2002
    Date of Patent: April 12, 2005
    Assignee: BASF
    Inventors: Markus Pompejus, Harald Seulberger, Hans Wolfgang Höffken, Jose Luis Revuelta Doval, Alberto Jimenez, Maria Angeles Santos Garcia
  • Publication number: 20030027309
    Abstract: Genes of purine biosynthesis from Ashbya gossypii are used in microbial riboflavin synthesis.
    Type: Application
    Filed: February 15, 2002
    Publication date: February 6, 2003
    Inventors: Markus Pompejus, Harald Seulberger, Hans Wolfgang Hoffken, Jose Luis Revuelta Doval, Alberto Jimenez, Maria Angeles Santos Garcia
  • Patent number: 6489147
    Abstract: A gene which contains the nucleotide sequence shown in SEQ ID NO:1 from nucleotide 671 to nucleotide 6295 or a nucleotide sequence which can be obtained therefrom by substitution, insertion or deletion of up to 30%, preferably up to 10%, particularly preferably up to 20%, especially preferably up to 5%, of the nucleotides, and whose gene product has the enzymatic activity of an adenylate cyclase, and its use.
    Type: Grant
    Filed: June 21, 1999
    Date of Patent: December 3, 2002
    Assignee: BASF Aktiengesellschaft
    Inventors: Regula Altmann-Jöhl, Peter Philippsen, Henning Althöfer, Harald Seulberger
  • Patent number: 6391603
    Abstract: Genes of purine biosynthesis from Ashbya gossypii are used in microbial riboflavin synthesis.
    Type: Grant
    Filed: December 16, 1998
    Date of Patent: May 21, 2002
    Assignee: BASF Aktiengesellschaft
    Inventors: Markus Pompejus, Harald Seulberger, Hans Wolfgang Höffken, Jose Luis Revuelta Doval, Alberto Jimenez, Maria Angeles Santos Garcia
  • Patent number: 6376216
    Abstract: A DNA sequence containing a) the primary structure shown in SEQ ID NO:1 position 9 to 307 or b) a primary structure which hybridizes with the double strand containing a) under standard conditions and which has essentially the same promoter activities as a) is suitable as promoter.
    Type: Grant
    Filed: June 21, 2000
    Date of Patent: April 23, 2002
    Assignee: BASF Aktiengesellschaft
    Inventors: Jose Luis Revuelta Doval, Maria Angeles Santos Garcia, Markus Pompejus, Harald Seulberger
  • Patent number: 6066502
    Abstract: The invention relates to endothelin-converting enzymes containing the polypeptide sequence described in SEQ. ID. NO. 30 or SEQ. ID. NO. 36 or functional fragments thereof, genes which code for such enzymes, and processes for producing the said enzymes and the use thereof.
    Type: Grant
    Filed: May 16, 1996
    Date of Patent: May 23, 2000
    Assignee: BASF Aktiengesellschaft
    Inventors: Burkhard Kroger, Harald Seulberger, Thomas Meyer, Martin Schmidt, Elard Jacob, Rainer Otter, Thomas Subkowski, Heinz Hillen
  • Patent number: 5976844
    Abstract: The disclosure concerns a process for the microbial preparation of riboflavin by culturing riboflavin-producing microorganisms in a nutrient medium and then isolating the riboflavin which has been produced, which comprises using microorganisms in which the endogenous isocitrate lyase (ICL) activity has been altered.
    Type: Grant
    Filed: May 1, 1998
    Date of Patent: November 2, 1999
    Assignee: BASF Aktiengesellschaft
    Inventors: Bruno Kasler, Hermann Sahm, Klaus-Peter Stahmann, Georg Schmidt, Theo Boddecker, Harald Seulberger